Nathanael Hoze






Lefrancq N, Paireau J, Hozé N, Courtejoie N, Yazdanpanah Y, Bouadma L, Boelle PY, Chereau F, Salje H, Cauchemez S. (2021). Evolution of outcomes for patients hospitalised during the first 9 months of the SARS-CoV-2 pandemic in France: A retrospective national surveillance data analysis. The Lancet regional health. Europe, (5)

Diarra I, Nurtop E, Sangaré AK, Sagara I, Pastorino B, Sacko S, Zeguimé A, Coulibaly D, Fofana B, Gallian P, Priet S, Drexler JF, Failloux AB, Dabo A, Thera MA, Djimdé A, Kouriba B, Cauchemez S, de Lamballerie X, Hozé N, Doumbo OK. (2020). Zika Virus Circulation in Mali. Emerging infectious diseases, 26(5)

Salje H, Tran Kiem C, Lefrancq N, Courtejoie N, Bosetti P, Paireau J, Andronico A, Hozé N, Richet J, Dubost CL, Le Strat Y, Lessler J, Lévy-Bruhl D, Fontanet A, Opatowski L, Boelle PY, Cauchemez S. (2020). Estimating the burden of SARS-CoV-2 in France. Science (New York, N.Y.)

Hozé N, Salje H, Rousset D, Fritzell C, Vanhomwegen J, Bailly S, Najm M, Enfissi A, Manuguerra JC, Flamand C, Cauchemez S. (2020). Reconstructing Mayaro virus circulation in French Guiana shows frequent spillovers. Nature communications, 11(1)

Capai L, Hozé N, Chiaroni J, Gross S, Djoudi R, Charrel R, Izopet J, Bosseur F, Priet S, Cauchemez S, de Lamballerie X, Falchi A, Gallian P. (2020). Seroprevalence of hepatitis E virus among blood donors on Corsica, France, 2017. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 25(5)

Cauchemez S, Hoze N, Cousien A, Nikolay B, Ten Bosch Q. (2019). How Modelling Can Enhance the Analysis of Imperfect Epidemic Data. Trends in parasitology, 35(5)

Scire J, Hozé N, Uecker H. (2019). Aggressive or moderate drug therapy for infectious diseases? Trade-offs between different treatment goals at the individual and population levels. PLoS computational biology, 15(8)

If you’d like to update your profile, please email modifications to

This site is registered on as a development site.